Interactions of sodium selenite, glutathione, arsenic species, and omega class human glutathione transferase

Chemical Research in Toxicology

Volumn 18, Issue 8, 2005, Pages 1287-1295

  Zakharyan, Robert A ^a,b   Tsaprailis, George ^a   Chowdhury, Uttam K ^a   Hernandez, Alba ^a,c   Aposhian, H Vasken ^a,b  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC ACID; ARSENIC DERIVATIVE; CYSTEINE; DISULFIDE; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; IODOACETAMIDE; METHANEARSONIC ACID; SELENIUM; SODIUM SELENITE; SUPEROXIDE;

ALKYLATION; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; COVALENT BOND; ENZYME ACTIVE SITE; ENZYME INHIBITOR INTERACTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; OXIDATIVE PHOSPHORYLATION; PROTEIN ANALYSIS; REACTION ANALYSIS;

AMINO ACID SEQUENCE; ARSENICALS; CYSTEINE; DITHIOTHREITOL; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; SODIUM SELENITE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STEREOISOMERISM; SULFHYDRYL COMPOUNDS;

EID: 23844491521     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0500530     Document Type: Article

References (68)

1. III), excreted in human urine. Toxicol. Appl. Pharmacol. 165, 74-83.
2. Thomas, D. J., Styblo, M., and Lin, S. (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
3. Vahter, M. (1994) Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8, 175-182.
4. Le, X. C., Ma, M., Lu, X., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000) Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108, 1015-1018.
5. Rossman, T. G. (2003) Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533, 37-65.
6. Abernathy, C. O., Thomas, D. J., and Calderon, R. L. (2003) Health effects and risk assessment of arsenic. J. Nutr. 133, 1536S-1538S.
7. Waalkes, M. P., Liu, J., Ward, J. M., and Diwan, B. A. (2004) Mechanisms underlying arsenic carcinogenesis: Hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 198, 31-38.
8. Cohen, S. M., Yamamoto, S., Cano, M., and Arnold, L. L. (2001) Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicol. Sci. 59, 68-74.
9. Liu, J., Kadiiska, M. B., Liu, Y., Tong, L., Qu, W., and Waalkes, M. P. (2001) Stress-related gene expression in mice treated with inorganic arsenicale. Toxicol. Sci. 61, 314-320.
10. Schuliga, M., Chouchane, S., and Snow, E. T. (2002) Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol. Sci. 70, 183-192.
11. Hirano, S. K., Kobayashi, Y., Cui, X., Kanno, S., Tayakawa, T., and Shraim, A. (2004) The accumulation and toxicity of methylated arsenicale in endothelial cells: Important roles of thiol compounds. Toxicol. Appl. Pharmacol. 198, 458-467.
12. Holmberg, R. E., and Ferm, V. H. (1960) Interrelationship of selenium, cadmium, and arsenic in mammalian teratogenesis. Arch. Environ. Health 18, 873-888.
13. Ueda, H., Kuroda, K., and Endo, G. (1997) The inhibitory effect of selenium on induction of tetraploidy by dimethylarsinic acid in Chinese hamster cells. Anticancer Res. 17, 1939-1944.
14. Biswas, S., Talukder, G., and Sharma, A. (1999) Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat. Res. 441, 155-160.
15. Swiens, A. (1983) Protective effects of selenium against arsenic-induced chromosomal damage in cultured human hepatocytes. Hereditas 98, 249-252.
16. Levander, O. A., and Baumann, C. A. (1966) Selenium metabolism: VI. Effects of arsenic on the excretion of selenium in the bile. Toxicol. Appl. Pharmacol. 9, 106-115.
17. Kenyon, E. M., Hughes, M. F., and Levander, O. A. (1997) Influence of dietary selenium on the disposition of arsenate in the female B6C3F mouse 1. J. Toxicol. Environ. Health 51, 279-299.
18. Csanaky, I., and Gregus, Z. (2003) Effect of selenite on the disposition of arsenate and arsenite in rats. Toxicology 186, 33-50.
19. Taketani, S., Kohno, H., Tokunaga, R., Ishii, T., and Bannai, S. (1991) Selenium antagonizes the induction of human heme oxygenase by arsenite and cadmium ions. Biochem. Int. 23, 625-632.
20. Gailer, J., George, G. N., Pickering, I. J., Prince, R. C., Ringwald, S. C., Pemberton, J. E., Glass, R. S., Yonis, H. S., DeYoung, D. W., and Aposhian, H. V. (2000) A metabolic link between arsenite and selenite: The seleno-bis (S-glutathionyl) arsinium ion. J. Am. Chem. Soc. 122, 4637-4639.
21. Stewart, M. S., Spallholz, J. E., Neldner, K. H., and Pence, B. C. (1999) Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radical Biol. Med. 26, 42-48.
22. Birringer, M., Pilawa, S., and Flohe, L. (2002) Trends in selenium biochemistry. Nat. Prod. Rep. 19, 693-718.
23. Styblo, M., and Thomas, D. J. (2001) Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes. Toxicol. Appl. Pharmacol. 172, 52-61.
24. Zakharyan, R. A., and Aposhian, H. V. (1999) Enzymatic reduction of arsenic compounds in mammalian systems: The rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem. Res. Toxicol. 12, 1278-1283.
25. Radabaugh, T. R., and Aposhian, H. V. (2000) Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 13, 26-30.
26. Radabaugh, T. R., Sampayo-Reyes, A., Zakharyan, R. A., and Aposhian, H. V. (2002) Arsenate reductase II. Purine nuceloside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15, 692-698.
27. Gregus, Z., and Nemeti, B. (2002) Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70, 13-19.
28. Aposhian, H. V., Zakharyan, R. A., Avram, M. D., Sampayo-Reyes, A., and Wollenberg, M. L. (2004) A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol. Appl. Pharmacol. 198, 327-335.
29. Zakharyan, R. A., Wu, Y., Bogdan, G. M., and Aposhian, H. V. (1995) Enzymatic methylation of arsenic compounds: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8, 1029-1038.
30. Zakharyan, R. A., Wildfang, E., and Aposhian, H. V. (1996) Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin but not the rhesus monkeys are deficient in methyltransferases that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 140, 77-84.
31. Lin, S., Shi, Q., Nix, F. B., Styblo, M., Beck, M. A., Herbin-Davis, K. M., Hall, L. L., Simeonsson, J. B., and Thomas, D. J. (2002) A novel S-adenosyl-L-methionine: Arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277, 10795-10803.
32. V) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14, 1051-1057.
33. III) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158, 9-15.
34. Walton, F. S., Waters, S. B., Jolley, S. L., LeCluyse, E. L., Thomas, D. J., and Styblo, M. (2003) Selenium compounds modulate the activity of recombinant rat As(III)-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem. Res. Toxicol. 16, 261-265.
35. Hayes, D., Flanagan, J. U., and Jowsey, I. R. (2005) Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88.
36. Board, P. G., Coggan, M., Chelvanayagam, G., Easteal, S., Jermiin, L. S., Schulte, G. K., Danley, D. E., Hoth, L. R., Griffor, M. C., Kamath, A. V., Rosner, M. H., Chrunyk, B. A., Perregaux, D. E., Gabel, C. A., Geoghegan, K. F., and Pandit, J. (2000) Identification, characterization, and crystal structure of the omega class glutathione transferases. J. Biol. Chem. 275, 24798-24806.
37. Schmuck, E. M., Board, P. G., Whitbread, A. K., Tetlow, N., Cavanaugh, J. A., Bluckburn, A. C., and Masoumi, A. (2004) Characterization of the monomethylarsenate reductase and dehydroascorbate reductase activities of omega class glutathione transferase variants. Implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases. Pharmacogenetics, in press.
38. Dulhunty, A., Gage, P., Curtis, S., Chelvanayagam, G., and Board, P. G. (2001) The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem. 276, 3319-3323.
39. Yin, Z.-L., Dahlstrom, J. E., LeCouteur, D. G., and Board, P. G. (2001) Immunohistochemistry of omega class glutathione S-transferase in human tissues. J. Histochem. Cytochem. 49, 983-988.
40. Sampayo-Reyes, A., Zakharyan, R. A., Healy, S. M., and Aposhian, H. V. (2000) Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 13, 1181-1186.
41. Laliberte, R. E., Perregaux, D. G., Hoth, L. R., Rosner, P. J., Jordan, C. K., Peese, K. M., Eggler, J. F., Dombroski, M. A., Geoghegan, K. F., and Gabel, C. A. (2003) Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1 beta posttranslational processing. J. Biol. Chem. 278, 16567-16578.
42. Tanaka-Kagawa, T., Jinno, H., Hasegawa, T., Makino, Y., Seko, Y., Hanioka, N., and Ando, M. (2003) Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). Biochem. Biophys. Res. Commun. 301, 516-520.
43. International Agency for Research on Cancer (1987) in IARC Monograph on the Evaluation of Carcinogenic Risk to Humans: Overall Evaluation of Carcinogenicity: An Update of IARC Monographs 1 to 42, Suppl. 7, p 100, International Agency for Research on Cancer, Lyon.
44. Casagrande, S., Bonetto, V., Fratelli, M., Giahazza, E., Eberini, I. Massignan, T., Salmona, M., Chang, G., Holmgren, A., and Ghezzi, P. (2002) Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems. Proc. Natl. Acad. Sci. U.S.A. 99, 9745-9749.
45. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858.
46. Eng, J. K., McCormack, A. L., and Yates, J. R., III (1994) An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein. Database J. Am. Soc. Mass. Spectrom. 5, 976-989.
47. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
48. Painter, E. P. (1941) The chemistry and toxicity of selenium compounds, with special reference to the selenium problem. Chem. Rev. 28, 179-213.
49. Ganther, H. E. (1968) Selenotrisulfides. Formation by reaction of thiols with selenious acid. Biochemistry 7, 2898-2905.
50. Hsieh, H. S., and Ganther, H. E. (1975) Acid-volatile selenium formation catalyzed by glutathione reductase. Biochemistry 14, 1632-1636.
51. Ganther, H. E. (1999) Selenium metabolism, selenoproteins, and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis 20 (9), 1657-1666.
52. Seko, Y., Saito, Y., Kitahara, J., and Imura, N. (1989) Active oxygen generation by the reaction of selenite with reduced glutathione in vitro. In Selenium in Biology and Medicine (Wendel, A., Ed.) pp 70-73, Springer, Berlin.
53. Terada, A., Yoshida, M., Seko, Y., Kobayashi, T., Yoshida, K., Nakada, M., Nakada, K., Echizen, H., Ogata, H., and Rikihisa, T. (1999) Active oxygen species generation and cellular damage by additives of parenteral preparations: Selenium and sulfhydryl compounds. Nutrition 15, 651-655.
54. Yan, L., and Spallholz, J. E. (1993) Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem. Pharmacol. 45, 429-437.
55. Spallholz, J. E., Zhang, X., and Boylan, L. M. (1993) Generation of oxyradicals by selenium compounds. FASEB J. A290, 1683.
56. Shiobara, Y., and Suzuki, K. T. (1998) Binding of selenium (administered as selenite) to albumin after efflux from red blood cells. J. Chromatogr. B: Biomed. Sci. Appl. 710 (1-2), 49-56.
57. Suzuki, K. T., and Ogra, Y. (2002) Metabolic pathway for selenium in the body: Speciation by HPLC-ICP-MS with enriched Se. Food Addit. Contam. 19, 974-983.
58. Islam, F., Watanabe, Y., Morii, H., and Hayaishi, O. (1991) Inhibition of rat brain prostaglandin-D synthase by inorganic selenocompounds. Arch. Biochem. Biophys. 289, 161-166.
59. Spyrou, G., Bjornstedt, M., Kumar, S., and Holmgren, A. (1995) AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett. 368, 59-63.
60. Kim, I. Y., and Stadtman, T. C. (1997) Inhibition of NF-kB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc. Natl. Acad. Sci. U.S.A. 94, 12904-12907.
61. Park, H.-S., Huh, S.-U., Kim, Y., Shim, J., Lee, S.-H., Park, S., Jung, Y.-K., Kim, I. Y., and Choi, E.-J. (2000) Selenite negatively regulates caspase-3 through a redox mechanism. J. Biol. Chem. 275 (12), 8487-8491.
62. Dickson, R. C., and Tappel, A. L. (1969) Effects of selenocysteine and selenomethionine on activation of sulfhydryl enzymes. Arch. Biochem. Biophys. 131, 100-110.
63. Singh, R., and Whitesides, G. M. (1991) Selenols catalyze the interchange reactions of dithiols and disulfides in water. J. Org. Chem. 56, 6931-6933.
64. Singh, R., and Kats, L. (1995) Catalysis of reduction of disulfides by selenol. Anal. Biochem. 232, 86-91.
65. Donaldson, W. E. (1977) Selenium inhibition of avian fatty acid synthetase complex. Chem.-Biol. Interact. 17, 313-320.
66. Self, W. T., Tsai, L., and Stadtman, T. C. (2000) Synthesis and characterization of selenotrisulfide-derivatives of lipoic acid and lipoamide. Proc. Natl. Acad. Sci. U.S.A. 97 (23), 12481-12486.
67. Zhang, J.-S., Gao, X.-Y., Zhang, L.-D., and Bao, Y.-P. (2001) Biological effects of a nano red elemental selenium. Biofactors 15, 27-38.
68. Aposhian, H. V., Zakharyan, R. A., Avram, M. D., Kopplin, M. J., and Wollenberg, M. L. (2003) Oxidation and detoxification of trivalent arsenic species. Toxicol. Appl. Pharmacol. 193, 1-8.